Stocks and Investing Stocks and Investing
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022

Andrew Fein Maintained (APRE) at Hold with Decreased Target to $40 on, Mar 16th, 2022


Published on 2024-10-27 20:06:46 - WOPRAI, Andrew Fein
  Print publication without navigation


Andrew Fein of HC Wainwright & Co., Maintained "Aprea Therapeutics, Inc." (APRE) at Hold with Decreased Target from $80 to $40 on, Mar 16th, 2022.

Andrew, nor any peers, have made any analyst calls on APRE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30